Objective 6: A strong collaborative research agenda across all sectors

Objective Six of the National AMR Strategy – 2020 and Beyond is to develop a national research agenda. This will advance the discovery of new therapies and diagnostics and innovative ways to prevent, detect and contain AMR.

Why is this important?

Research is essential to:

  • understand how to reduce antibiotic use
  • investigate alternatives to antibiotics
  • develop new antibiotics
  • develop new diagnostic technologies.

Research will also help us better understand how resistance develops and how resistant bacteria transfer between:

  • animals
  • the environment
  • food
  • people.

View the full details of Objective Six of the National AMR Strategy – 2020 and Beyond, including specific priority areas of action.

What are we doing?

The National Health and Medical Research Council (NHMRC) funds Centres of Research Excellence to investigate all aspects of AMR. These include: 

Research into AMR is a priority of the Medical Research Future Fund.

Australia contributes to research on AMR through Product Development Partnerships. Two diseases that we are currently researching are how we can combat malaria and tuberculosis in our region, including resistant strains.

The Institute for Molecular Biosciences Centre for Superbug Solutions undertakes research to:

  • develop a point of care diagnostic
  • find new antibiotics  to develop new drugs
  • discover new compounds with antimicrobial properties.

Universities across Australia are increasing the research work they currently do into AMR in the animal health sector.

As part of our Budget 2020–21 initiatives we are:

Find out more about what partners from across Australia are doing to support Objective Six of the National AMR Strategy – 2020 and Beyond.

Share your activity or research project that supports Objective Six of the National AMR Strategy – 2020 and Beyond.

Last updated: 
12 August 2020